Argentina Head And Neck Cancer Therapeutics Market Size & Outlook
Related Markets
Argentina head and neck cancer therapeutics market highlights
- The Argentina head and neck cancer therapeutics market generated a revenue of USD 11.5 million in 2024 and is expected to reach USD 37.9 million by 2033.
- The Argentina market is expected to grow at a CAGR of 14.3% from 2025 to 2033.
- In terms of segment, immunotherapy was the largest revenue generating type in 2024.
- Targeted Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Head and neck cancer therapeutics market data book summary
| Market revenue in 2024 | USD 11.5 million |
| Market revenue in 2033 | USD 37.9 million |
| Growth rate | 14.3% (CAGR from 2025 to 2033) |
| Largest segment | Immunotherapy |
| Fastest growing segment | Targeted Therapy |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy, Immunotherapy, Targeted Therapy |
| Key market players worldwide | Eli Lilly and Co, Sanofi SA, Merck & Co Inc, Bristol-Myers Squibb Co, AstraZeneca PLC, Takeda Pharmaceutical Co Ltd, Teva Pharmaceutical Industries Ltd, Roche Holding AG ADR, Clinigen Group |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.5% of the global head and neck cancer therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil head and neck cancer therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 37.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Head And Neck Cancer Therapeutics Market Scope
Head And Neck Cancer Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Argentina head and neck cancer therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to head and neck cancer therapeutics market will help companies and investors design strategic landscapes.
Immunotherapy was the largest segment with a revenue share of 68.7% in 2024. Horizon Databook has segmented the Argentina head and neck cancer therapeutics market based on chemotherapy, immunotherapy, targeted therapy covering the revenue growth of each sub-segment from 2021 to 2033.
Constant developments by market players, such as geographic expansion and new product launches, have contributed to Argentina’s market growth. Furthermore, the considerable prevalence of head and neck cancer, coupled with rising demand for advanced therapeutics, is expected to boost market growth over the forecast period.
There has been a steady rise in the number of oncologists in recent years, especially in Brazil and Argentina, as well as increase in awareness about the scarcity of cancer specialists in the region. To enhance & promote the activities in the region, a regional facility has been established at the National Cancer Institute of Argentina (Instituto Nacional del Cáncer de Argentina) in Buenos Aires.
Furthermore, the country annually attracts several international medical tourists seeking non-conventional treatments. The Unique Reimbursement System (SUR, after its acronym in Spanish) is described in SSS Regulation No. 1,200/2012, as amended and supplemented, and is meant to provide financial support to Health Insurance Agents in the reimbursement of specific treatments of diseases with high economic impact, long-term treatment requirements, and low incidence.
Reasons to subscribe to Argentina head and neck cancer therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina head and neck cancer therapeutics market databook
-
Our clientele includes a mix of head and neck cancer therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina head and neck cancer therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina head and neck cancer therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina head and neck cancer therapeutics market size, by type, 2021-2033 (US$M)
Argentina Head And Neck Cancer Therapeutics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
